Evidence map›Paper›PMID 26238334›Full record

ArticleScientific reports2015

Comprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers.

Joshua T Dearborn, Steven K Harmon, Stephen C Fowler, Karen L O'Malley, George T Taylor, Mark S Sands, David F Wozniak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. GABATranslational psychiatry · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.Autism research : official journal of the International Society for Autism Research · 2018
    Article
  18. Synergistic effects of treating the spinal cord and brain in CLN1 disease.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Joshua T DearbornDepartment of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Steven K HarmonDepartment of Anatomy and Neurobiology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Stephen C FowlerDepartment of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, USA.
Karen L O'MalleyDepartment of Anatomy and Neurobiology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
George T TaylorDepartment of Psychology, University of Missouri-St. Louis, St. Louis, MO, USA.
Mark S SandsDepartment of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
David F Wozniak1] Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO, USA [2] The Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Washington University in St. Louis · USUniversity of Kansas · USUniversity of Missouri–St. Louis · US

Funding

Research Design and Analysis Core (RDAC)P30HD002528 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 1985 to 2015
$22.1M
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCERT32CA009547 · NCI · WASHINGTON UNIVERSITY · PI ROBERT DAVID SCHREIBER · 1986 to 2026
$12.1M
Washington University Intellectual and Developmental Disabilities Research Center-Administrative Down Syndrome SupplementU54HD087011 · NICHD · WASHINGTON UNIVERSITY · PI MOLEY, KELLE H · 2015 to 2019
$7.1M
Washington University Intellectual and Developmental Disabilities Research CenterP30HD062171 · NICHD · WASHINGTON UNIVERSITY · PI CONSTANTINO, JOHN N. · 2010 to 2014
$4.3M
PATHOPHYSIOLOGY AND NOVEL THERAPIES FOR BATTEN'S DISEASER01NS043205 · NINDS · WASHINGTON UNIVERSITY · PI SANDS, MARK S · 2003 to 2016
$4.0M
NCI NIH HHS T32 CA009547NICHD NIH HHS P30 HD002528NICHD NIH HHS P30 HD02528NICHD NIH HHS P30 HD062171NICHD NIH HHS U54 HD087011NINDS NIH HHS R01 NS043205
6 · The paper itself

Abstract

Infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease) is a neurodegenerative lysosomal storage disease caused by a deficiency in palmitoyl protein thioesterase-1 (PPT1). The PPT1-deficient mouse (Cln1(-/-)) is a useful phenocopy of human INCL. Cln1(-/-) mice display retinal dysfunction, seizures, motor deficits, and die at ~8 months of age. However, little is known about the cognitive and behavioral functions of Cln1(-/-) mice during disease progression. In the present study, younger (~1-2 months of age) Cln1(-/-) mice showed minor deficits in motor/sensorimotor functions while older (~5-6 months of age) Cln1(-/-) mice exhibited more severe impairments, including decreased locomotor activity, inferior cued water maze performance, decreased running wheel ability, and altered auditory cue conditioning. Unexpectedly, certain cognitive functions such as some learning and memory capabilities seemed intact in older Cln1(-/-) mice. Younger and older Cln1(-/-) mice presented with walking initiation defects, gait abnormalities, and slowed movements, which are analogous to some symptoms reported in INCL and parkinsonism. However, there was no evidence of alterations in dopaminergic markers in Cln1(-/-) mice. Results from this study demonstrate quantifiable changes in behavioral functions during progression of murine INCL and suggest that Parkinson-like motor/sensorimotor deficits in Cln1(-/-) mice are not mediated by dopamine deficiency.

Indexed as

AnimalsDisease Models, AnimalDisease ProgressionDopamineDopaminergic NeuronsFemaleGene ExpressionHumansMaleMaze LearningMiceMice, KnockoutMotor ActivityNeuronal Ceroid-LipofuscinosesParkinson Disease, SecondaryPattern Recognition, PhysiologicalDopaminepalmitoyl-protein thioesteraseThiolester Hydrolases

Identifiers

PMID26238334
PMCPMC4523849
OpenAlexW1159100168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.